Association of Body Mass Index With Postoperative Complications After Chest Masculinization Surgery
Authors:
- Camille BlackmanCamille Blackman
- Margaret WangMWMargaret Wang
- 18 August 2025
- journal article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 95 (5) , 543-552
Abstract
Background: Institutional preoperative body mass index (BMI) cutoffs for chest masculinization surgery (CMS) lack standardization and are based on limited data. After our group's NSQIP study found no severe morbidity or mortality in patients of higher BMI, we eliminated BMI cutoffs and collected additional measurements such as aesthetic and wound healing outcomes. This is a single-institution follow-up study to evaluate CMS outcomes in higher BMI patients to better guide preoperative planning and patient counseling. Methods: We conducted a retrospective, single-surgeon cohort study of patients who underwent CMS with double-incision mastectomy and free nipple grafting between November 2022 and January 2025, after elimination of BMI cutoffs. Primary outcomes included postoperative surgical complications requiring intervention and adverse aesthetic outcomes. We also collected major complications (e.g., venous thromboembolism, pulmonary embolism, sepsis, acute kidney injury). We analyzed BMI as both a continuous and a categorical variable per WHO guidelines, adjusting for confounders. Results: Among 92 patients, the mean (SD) BMI was 32.2 (7.3) kg/m 2 . Surgical complications occurred in 20.7% (n = 19) of patients, of which most were superficial surgical site infections (12.0%, n = 11). No major complications occurred except for one case requiring blood transfusion for postoperative anemia (1.1%). Each 1-kg/m 2 increase in BMI was associated with 10% higher odds of infection (aOR, 1.10; 95% CI, 1.01–1.20; P = 0.029). Adverse aesthetic outcomes occurred in 32.6% of patients (n = 30), with each 1-kg/m 2 BMI increase associated with 12% higher odds of scar widening/hypertrophy and standing cone deformity (aOR, 1.12; 95% CI, 1.04–1.20; P = 0.002). Conclusions: Higher BMI was associated with increased risk of surgical site infection and adverse aesthetic outcomes following CMS. Major complications remained rare. Surgeons should avoid using BMI as an absolute contraindication and adopt a risk-stratified approach to guide care.Keywords
This publication has 18 references indexed in Scilit:
- Association Between Body Mass Index and Clinical Outcomes of Gender-Affirming Masculinizing Chest ReconstructionJournal of Surgical Research, 2024
- Effect of obesity on perioperative outcomes following gastrointestinal surgery: meta-analysisBJS Open, 2023
- Delays in gender affirming healthcare due to COVID-19 are mitigated by expansion of telemedicineThe American Journal of Surgery, 2022
- Systematic review and meta-analysis: association between obesity/overweight and surgical complications in IBDInternational Journal of Colorectal Disease, 2022
- Surgical and patient-reported outcomes following double incision and free nipple grafting for female to male gender affirmation: does obesity make a difference?Journal of Plastic, Reconstructive & Aesthetic Surgery, 2021
- Body Mass Index Requirements for Gender-Affirming Surgeries Are Not Empirically BasedTransgender Health, 2021
- Clinical Faceoff: Should Orthopaedic Surgeons Have Strict BMI Cutoffs for Performing Primary TKA and THA?Clinical Orthopaedics and Related Research, 2019
- Quality of life improvement after chest wall masculinization in female-to-male transgender patients: A prospective study using the BREAST-Q and Body Uneasiness TestJournal of Plastic, Reconstructive & Aesthetic Surgery, 2018
- Limitations of body mass index as an obesity measure of perioperative riskBritish Journal of Anaesthesia, 2016
- Obesity and complications in breast reduction surgery: are restrictions justified?Journal of Plastic, Reconstructive & Aesthetic Surgery, 2009